"Obesity induces hypoxia and upregulation of HIF-2α in the gastrointestinal tract, resulting in excess ceramide pro… https://t.co/hInC90bXbL
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
Intestinal HIF-2α, a novel target for the treatment of fatty liver disease, which can lead to cancer. https://t.co/KNo9k3FZz8
Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis. https://t.co/S1zHp6maFe
RT @AlpBugraBasat: https://t.co/jT7PKad89z An interesting paper about HIF-NASH relationship. $AKBA $FGEN
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
https://t.co/jT7PKad89z An interesting paper about HIF-NASH relationship. $AKBA $FGEN
Pranayama might improve liver health by increasing oxygen supply to intestine https://t.co/oUt93TrGvf
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
Activation of intestinal hypoxia-inducible factor 2[alpha] during obesity contributes to hepatic steatosis https://t.co/jvC2eUJvrS
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
Peloton Therapeutics has a HIF-2 alpha antagonist https://t.co/5NbLbTU787 Maybe $GILD should consider buying (even the whole TCG portfolio) https://t.co/XZE4akhLva
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
HIF2αが肝線維化治療ターゲットになるか? 非アルコール性肝炎関連 https://t.co/1tqQNcnwEn
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
RT @NatureMedicine: New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f ht…
New study suggests intestinal HIF-2α could be a viable target for hepatic steatosis therapy: https://t.co/ZAelxKxp5f https://t.co/ceVRNODvx1
RT @NCIResearchCtr: #CCRAdvance Activation of intestinal hypoxia-inducible factor 2alpha during obesity contributes to hepatic steatosis ht…
#CCRAdvance Activation of intestinal hypoxia-inducible factor 2alpha during obesity contributes to hepatic steatosis https://t.co/7KYmNCqown
Activation of intestinal hypoxia-inducible factor 2[alpha] during obesity contributes to hepatic steatosis https://t.co/MgyqTcANE2 https://t.co/HdWaBn3kM5
RT @DanielJDrucker: Genetic/Chemical Targeting of Obesity-induced Intestinal Hypoxia-inducible Factor 2alpha to Rx NAFLD @NatureMedicine ht…
Genetic/Chemical Targeting of Obesity-induced Intestinal Hypoxia-inducible Factor 2alpha to Rx NAFLD @NatureMedicine https://t.co/8eCpdTsK3f
Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis https://t.co/cYx2aHeBqw